![Heather Turner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Heather Turner
Vorstandsvorsitzender bei
LB PHARMACEUTICALS INC
Vermögen: - $ am 31.05.2026
Profil
Heather D.
Turner is Chief Executive Officer & Director at LB Pharmaceuticals, Inc. since 2024.
Ms. Turner is Chairman at Avalyn Pharma, Inc. since 2024.
Ms. Turner is a Member of The State Bar of California.
Former positions include President, Chief Executive Officer & Director at Carmot Therapeutics, Inc.; Independent Director at Terns Pharmaceuticals, Inc. from 2024 to 2026; Senior Vice President & General Counsel at Sangamo Therapeutics, Inc. from 2018 to 2019; Associate General Counsel at Conor Medsystems LLC from 2005 to 2007; Secretary, Senior Vice President & General Counsel at Orexigen Therapeutics, Inc. from 2012 to 2015; Associate at Cooley LLP from 1999 to 2005; Secretary, Executive VP & General Counsel at Atara Biotherapeutics, Inc. from 2015 to 2018; and Secretary & Chief General Counsel at Lyell Immunopharma, Inc. from 2019 to 2023.
Education includes undergraduate studies at the University of California, Santa Barbara and graduate studies at UCLA School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AVALYN PHARMA INC -.--% | 30.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Heather Turner
| Unternehmen | Position | Beginn |
|---|---|---|
| LB PHARMACEUTICALS INC | Vorstandsvorsitzender | 19.11.2024 |
| AVALYN PHARMA INC. | Vorsitzender | 01.10.2024 |
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services Operates as a official attorney licensing agency | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Heather Turner
| Unternehmen | Position | Ende |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 05.05.2026 |
| LYELL IMMUNOPHARMA, INC. | General Counsel | 05.07.2023 |
| SANGAMO THERAPEUTICS, INC. | General Counsel | 15.03.2019 |
| ATARA BIOTHERAPEUTICS, INC. | General Counsel | 01.02.2018 |
| OREXIGEN THERAPEUTICS, INC. | General Counsel | 25.06.2015 |
Ausbildung von Heather Turner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Conor Medsystems LLC
 Conor Medsystems LLC Medical SpecialtiesHealth Technology Develops vascular drug delivery technologies | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services Operates as a official attorney licensing agency | Commercial Services |
UCLA School of Law
 UCLA School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Carmot Therapeutics, Inc.
 Carmot Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops drugs for inflammatory, metabolic and neurological diseases | Health Technology |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Wählen Sie MarketScreener 
